Have a feature idea you'd love to see implemented?
Let us know!
Price (delayed)
$242.57
Market cap
$20.29B
P/E Ratio
45.68
Dividend/share
$2.16
EPS
$5.31
Enterprise value
$26.49B
Laboratory Corporation of America Holdings, more commonly known as LabCorp, is an American S&P 500 company headquartered in Burlington, North Carolina. It operates one of the largest clinical laboratory networks
Highlights
The quick ratio has soared by 77% from the previous quarter and by 15% YoY
The gross profit has increased by 6% year-on-year
The price to earnings (P/E) is 93% higher than the 5-year quarterly average of 23.8 and 8% higher than the last 4 quarters average of 42.5
LH's net income is down by 34% YoY and by 3.1% from the previous quarter
Key stats
What are the main financial stats of LH
Market
Valuations
Earnings
Shares outstanding
83.64M
Market cap
$20.29B
Enterprise value
$26.49B
Price to earnings (P/E)
45.68
Price to book (P/B)
2.49
Price to sales (P/S)
1.6
EV/EBIT
32.26
EV/EBITDA
16.39
EV/Sales
2.08
Revenue
$12.71B
Gross profit
$3.55B
Net income
$435.5M
EBIT
$821.1M
EBITDA
$1.62B
Free cash flow
$843.2M
Per share
Balance sheet
Liquidity
EPS
$5.31
EPS diluted
$5.26
Free cash flow per share
$10.04
Book value per share
$97.31
Revenue per share
$151.41
TBVPS
$102.3
Total assets
$18.61B
Total liabilities
$10.43B
Debt
$7.72B
Equity
$8.17B
Working capital
$1.5B
Debt to equity
0.94
Current ratio
1.44
Quick ratio
1.1
Net debt/EBITDA
3.84
Margins
Efficiency
Dividend
EBITDA margin
12.7%
Gross margin
27.9%
Net margin
3.4%
Operating margin
5.9%
Return on assets
2.5%
Return on equity
5.4%
Return on invested capital
8.5%
Return on capital employed
5.4%
Return on sales
6.5%
Dividend yield
0.89%
DPS
$2.16
Payout ratio
40.7%
LH stock price
How has the Laboratory Corp Of America Holdings stock price performed over time
Intraday
-0.58%
1 week
2.22%
1 month
6.11%
1 year
7.44%
YTD
5.78%
QTD
5.78%
Financial performance
How have Laboratory Corp Of America Holdings's revenue and profit performed over time
Revenue
$12.71B
Gross profit
$3.55B
Operating income
$747.4M
Net income
$435.5M
Gross margin
27.9%
Net margin
3.4%
The net margin has declined by 38% year-on-year and by 6% since the previous quarter
LH's net income is down by 34% YoY and by 3.1% from the previous quarter
The operating margin has contracted by 19% YoY
Laboratory Corp Of America Holdings's operating income has decreased by 15% YoY
Growth
What is Laboratory Corp Of America Holdings's growth rate over time
Valuation
What is Laboratory Corp Of America Holdings stock price valuation
P/E
45.68
P/B
2.49
P/S
1.6
EV/EBIT
32.26
EV/EBITDA
16.39
EV/Sales
2.08
The price to earnings (P/E) is 93% higher than the 5-year quarterly average of 23.8 and 8% higher than the last 4 quarters average of 42.5
Laboratory Corp Of America Holdings's EPS has decreased by 30% YoY
The P/B is 9% higher than the 5-year quarterly average of 2.3 and 9% higher than the last 4 quarters average of 2.3
The company's equity rose by 3.8% YoY and by 2.1% QoQ
LH's price to sales (P/S) is 7% higher than its last 4 quarters average of 1.5
LH's revenue is up by 5% year-on-year
Efficiency
How efficient is Laboratory Corp Of America Holdings business performance
LH's ROA is down by 29% YoY and by 7% QoQ
LH's ROE is down by 24% YoY and by 5% QoQ
Laboratory Corp Of America Holdings's return on sales has decreased by 22% YoY and by 4.4% QoQ
The company's return on invested capital fell by 8% QoQ and by 3.4% YoY
Dividends
What is LH's dividend history
DPS
$2.16
Dividend yield
0.89%
Payout ratio
40.7%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Laboratory Corp Of America Holdings financials performed over time
LH's total assets is 79% greater than its total liabilities
The quick ratio has soared by 77% from the previous quarter and by 15% YoY
Laboratory Corp Of America Holdings's current ratio has soared by 64% from the previous quarter and by 6% YoY
The debt is 6% smaller than the equity
The debt has increased by 29% since the previous quarter and by 22% year-on-year
LH's debt to equity is up by 25% since the previous quarter and by 18% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.